Determination of Biological Activity of Three Allergen Extracts
NCT02474836 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 176
Last updated 2017-05-01
Summary
Allergen extracts are complex mixtures of proteins and contain varying amounts of allergenic and non-allergenic components. Many factors such as the variability, differences in extraction process and subsequent handling of allergens can affect the final composition, potency, and stability of allergen preparations. Genetic diversity of affected people adds another level of complexity. In order to control variability and to achieve consistency and reproducibility for optimal safety and sensitivity/specificity, it is essential to standardize the amount of allergen used in prick tests. Therefore, the system for biological standardization mainly used in Europe still is the biological calibration of in-House Reference Preparations (IHRP). The method has been adopted by the Nordic Council on Medicines as the Nordic Biological Unit, Histamine Equivalent Potency (HEP) or Skin Prick Test (SPT) value. The aim of this procedure is to estimate the biological activity of allergen extracts. The activity of an allergen extract is defined as 1 SPT per ml, when the extract provokes a specific skin reaction with a wheal of the same size as a wheal provoked by reference histamine at a concentration of 10 mg/ml, when both solutions are administrated using the same technique (prick testing) on at least 20 individuals who are sensitized to the allergen concerned.
The present study aims to standardize the allergen extracts of Artemisia vulgaris, Platanus acerifolia, Dermatophagoides farinae by using this method.
Conditions
Interventions
- BIOLOGICAL
-
Skin Prick Test - Atopic subjects
Skin prick test of 4 concentrations of each allergenic source, together with a positive and negative control, using 10 mg/ml histamine dihydrochloride solution and a glycerinated phenol saline solution, respectively, will be tested in every patient in duplicate on the volar surface of the forearm. Assessment of the wheal size after 15 minutes.
- BIOLOGICAL
-
Skin Prick Test - Non Atopic subjects
Skin prick test of 4 concentrations of each allergenic source, together with a positive and negative control, using 10 mg/ml histamine dihydrochloride solution and a glycerinated phenol saline solution, respectively, will be tested in every subjects in duplicate on the volar surface of the forearm. Assessment of the wheal size after 15 minutes.
- BIOLOGICAL
-
Skin Prick Test - Allergic subjects
Skin prick test of 4 concentrations of each allergenic source, together with a positive and negative control, using 10 mg/ml histamine dihydrochloride solution and a glycerinated phenol saline solution, respectively, will be tested in every patient in duplicate on the volar surface of the forearm. Assessment of the wheal size after 15 minutes.
Sponsors & Collaborators
-
Roxall Medicina España S.A
lead INDUSTRY
Principal Investigators
-
Araitz Landeta · Roxall Medicina España S.A
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-11-30
- Primary Completion
- 2013-09-30
- Completion
- 2013-09-30
Countries
- Spain
Study Locations
More Related Trials
-
Standardization of Chortoglyphus Arcuatus Allergenic Extract. Determination of Biological Activity in HEP Units
NCT00718744 ·Status: COMPLETED ·Phase: PHASE2
-
Biological Standardization of Dermatophagoides Pteronyssinus Allergen Extract
NCT01821716 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of a Depigmented Extract of Phleum in Local Allergic Rhinitis
NCT02126111 ·Status: COMPLETED ·Phase: PHASE2
-
Biological Standardization of Platanus Acerifolia Allergen Extract
NCT01739322 ·Status: COMPLETED ·Phase: PHASE2
-
Biological Standardization of Secale Cereale Allergen Extract
NCT01408238 ·Status: COMPLETED ·Phase: PHASE2
-
Biological Standardization of Lolium Perenne Allergen Extract
NCT01394289 ·Status: COMPLETED ·Phase: PHASE2
-
Determination of the Sensitivity and Specificity of Prick Test Betula Verrucosa
NCT02527187 ·Status: COMPLETED ·Phase: PHASE2
-
Threshold Concentrations for Ragweed and Birch Pollen in Seasonal Allergic Rhinitis
NCT05346718 ·Status: COMPLETED ·Phase: NA
-
Investigation of Safety+Efficacy of Different Doses of RagweedMATAMPL;Assessment of Residual Allergenicity Using Skin Prick Test
NCT00258635 ·Status: COMPLETED ·Phase: PHASE2
-
To Determine the Minimum Amount of Alternaria Alternata Allergen Extract Producing a Positive Skin Reaction.
NCT01984528 ·Status: COMPLETED ·Phase: PHASE2
-
Glycyphagus Domesticus Allergen Extract. Determination of the in Vivo Biological Activity in Histamine Equivalent Units (HEP).
NCT00917488 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma
NCT02340130 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study With Allergen Extracts of House Dust Mites for Specific Sublingual Immunotherapy
NCT01014325 ·Status: UNKNOWN ·Phase: PHASE3
-
Biological Standardization of Blomia Tropicalis Allergen Extract
NCT01597752 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Immunological Effect and Efficacy of the Combined Application of MPL and Grass Pollen Allergen
NCT00241410 ·Status: COMPLETED ·Phase: PHASE1
-
Biological Standarization of Cupressus Arizonica Allergen Extract to Determine the Biological Activity in Histamine Equivalent Units (HEP)
NCT02512653 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Efficacy and Safety of Specific Immunotherapy With Modified Allergen Extracts of House Dust Mites
NCT01013116 ·Status: UNKNOWN ·Phase: PHASE3
-
Juniperus Oxycedrus and Cupressus Arizonica Allergen Extracts Standardisation.
NCT05533385 ·Status: COMPLETED ·Phase: NA
-
Phase I/IIa Clinical Evaluation of AllerT vs Placebo in Subjects Allergic to Birch Pollen
NCT01728519 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Quercus Ilex and Quercus Robur Allergen Extracts Standardisation
NCT05532566 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety/Tolerability of Ragweed MATA MPL
NCT00423787 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of House Dust Mite Allergoid in the Treatment of Bronchial Asthma
NCT00263640 ·Status: COMPLETED ·Phase: PHASE3
-
Immunotherapy With Depigmented and Polymerized Allergen Extract of Phleum Pratense
NCT00501527 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract
NCT05641272 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Grass Pollen
NCT00916422 ·Status: COMPLETED ·Phase: PHASE3